DSG2 and Moyamoya disease: The main findings of this study are as follows: (a) DSG2 level decreased in patients with Moyamoya disease, (b) DSG2 affects PI3K signaling in vascular endothelial cells, and (c) MMP-9 is involved in DSG2-mediated vascular changes in Moyamoya disease.